LOBO NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

LOBO EV TECHNOLOGIES LTD. Ordinary shares · Consumer Cyclical · Auto Manufacturers

Open interactive chart View report data
Latest close 0.69 USD
-6.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 8.8% above the Trend Line and sits at 28.8% of its 52-week range. The latest completed week returned -6.5%, after a -4.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 65/100. Near-term considerations: volume confirmation is below normal.

Setup score 25 out of 100
Latest Close 0.69 USD 7 Aug 2026
1W Return -6.5% latest completed week
4W Return -4.2% short-term follow-through
12W Return -8.6% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.0x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 40.22% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.5% Latest completed week; four-week move -4.2%. Indicator stack 37/44 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.22% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 65/100 12 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.8% above the Trend Line and sits at 28.8% of its 52-week range. The latest completed week returned -6.5%, after a -4.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4412-week average 0.33

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.44Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.2% over four weeks, -8.6% over 12 weeks, and -7.5% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-6.5%
4W-4.2%
12W-8.6%
26W10.6%
52W-7.5%
Active trend streak6 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.06Latest activity-pressure read.
Pressure change-89.8%Four-week change in activity pressure.
Leadership-10.41Latest relative-leadership reading.
RS change-38.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 74%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength80/100Blend of value, momentum, and quality. Underlying universe rank 21; rank 1 is best.
Value65/100Relative valuation strength. Underlying universe rank 36; rank 1 is best.
Quality63/100Profitability and accounting quality. Underlying universe rank 38; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth65/100Revenue and earnings growth. Underlying universe rank 36; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-16.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
13.3%
Gross profit retained from each unit of revenue.
Operating margin
-17.5%
Operating profit retained from revenue.
Free-cash-flow margin
-9.2%
Free cash flow generated from revenue.
Return on invested capital
-28.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment65/100

Weighted news tone is positive across 12 relevant articles.

7 positive · 4 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-53.7%Distance below the 52-week high.
13-week volatility12.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+35.1%Week of 15 May.
Worst week-15.7%Week of 27 Mar.
Latest week-6.5%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses5
Sharp losses9
Recent vol12.1%13-week weekly-return volatility.
Base vol14.0%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew11.5% / -9.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape26/100

Trend, activity pressure, participation, and risk combine to a 26/100 tape read.

 Indicator analysis55/100

Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 3/12.

Activity pressure 0.44; No reversal markers Next-Week ExpectancyNegative 40.22%

Next-week expectancy is negative with a 40.22% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors68/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 43 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment65/100

Weighted news tone is positive across 12 relevant articles.

LOBO’s AI Products and Large Model API Services Surpass US$2 Million in Monthly Revenue Within Two Months of Operation Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20260.69 USD-6.5%0.63 USD1.38 USD0.06-10.4197.5KOn
31 Jul 20260.73 USD4.4%0.63 USD1.38 USD0.270.02354.2KOn
24 Jul 20260.70 USD1.9%0.62 USD1.39 USD0.33-4.25463.0KOn
17 Jul 20260.69 USD-3.8%0.62 USD1.39 USD0.44-7.19330.2KOn
10 Jul 20260.72 USD12.3%0.62 USD1.40 USD0.62-7.524.7MOn
3 Jul 20260.64 USD-7.5%0.63 USD1.40 USD0.70-16.00264.2KOn
26 Jun 20260.69 USD-12.5%0.64 USD1.41 USD0.92-8.47399.5KOff
19 Jun 20260.79 USD-0.5%0.64 USD1.42 USD1.04-0.09690.4KOff
12 Jun 20260.79 USD6.0%0.63 USD1.42 USD1.052.991.7MOff
5 Jun 20260.75 USD-5.4%0.63 USD1.43 USD1.08-0.6686.8MOff
29 May 20260.79 USD13.2%0.63 USD1.43 USD0.870.121.1MOff
22 May 20260.70 USD-6.9%0.64 USD1.44 USD0.83-9.512.5MOff
15 May 20260.75 USD35.1%0.65 USD1.45 USD0.89-3.2217.3MOff
8 May 20260.56 USD-13.8%0.66 USD1.45 USD0.65-29.84997.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context